期刊文献+

丹桔胶囊对血管紧张素Ⅱ损伤血管内皮功能的保护作用

Protective Effects and Mechanism of Danju Capsule on Angiotensin Ⅱ-Induced Dndothelial Dysfunction
原文传递
导出
摘要 目的:观察丹桔胶囊对血管紧张素Ⅱ(AngⅡ)损伤血管内皮功能的保护作用。方法:制备大鼠胸主动脉环,观察丹桔胶囊提取剂对抗AngⅡ引起的胸主动脉环收缩反应;AngⅡ刺激人脐静脉血管内皮细胞(HUVEC)以反转录—聚合酶链反应(RT-PCR)方法检测HUVEC的内皮素(ET-1)mRNA表达水平;蛋白质印迹(Western blot)方法检测HUVEC中细胞外信号调节激酶(extracellular signal-regulated kinase,ERK)和核转录因子κB(nuclear factorκB,NF-κB)的活化情况。结果:AngⅡ引起胸主动脉收缩,丹桔胶囊制剂能显著对抗血管收缩作用,下调AngⅡ刺激所致的HUVEC细胞ET-1 mRNA过度表达,抑制ERK1/2磷酸化,同时对NF-的活化表现出显著的抑制作用。p65位移、IκB-α磷酸化降解,丹桔胶囊上述抑制作用均呈现浓度依赖性。结论:丹桔胶囊抑制AngⅡ对血管内皮功能的损伤,其机制与降低ET-1表达,抑制ERK/NF-κB途径活化有关。 Objective:To observe the protective effect of Danju Capsule on vascular endothelial dysfunction induced by angiotensinⅡ(AngⅡ).Method:The Ang Ⅱ-induced contraction of rat aortic rings was tested in tissue bath.The expression of endothelin(ET)-1 mRNA was evaluated by RT-PCR in human umbilical vein endothelial cells(HUVEC) stimulated by Ang II.The activation of extracellular signal-regulated kinase(ERK) and nuclear transcription factor(NF-κB) and its inhibitor(IκB-α) were detected by Western blot in HUVEC.Result:The results showed that 1 × 10^-7 mol·L^-1 Ang Ⅱ increased contraction of rat aortic rings,ET-1mRNA expression,ERK1 /2 phosphorylation,NF-κB p65 displacement and IκB-α phosphorylation degradation,which were significantly inhibited by Danju Capsule in a dose-dependent manner.Conclusion:Ang Ⅱ may be involved in the initiation and progression of cardiovascular diseases by injuring vascular endothelium directly and causing endothelial dysfunction.Danju Capsule was shown to protect against Ang Ⅱ induced endothelial dysfunction,suggesting that Danju Capsule may play a role in the prevention and treatment of cardiovascular diseases.
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第6期202-206,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 南京市科技发展计划赞助项目(200805013)
关键词 丹桔胶囊 血管紧张素Ⅱ 主动脉 人脐静脉血管内皮细胞 内皮素 Danju Capsule angiotensin Ⅱ aorta human umbilical vein endothelial cells endothelin
  • 相关文献

参考文献10

二级参考文献28

  • 1中华人民共和国卫生部.中药新药临床研究指导原则(第1辑)[M].,1993.32-35.
  • 2国际心脏病学会和协会及WHO命名标准化联合专题组.缺血性心脏病命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-75.
  • 3王裕生.中药药理与应用[M].人民卫生出版社,1983.696.
  • 4夏奕明,卫生研究,1987年,16卷,4期,29页
  • 5八木国夫,临床验查(日),1985年,23卷,2期,115页
  • 6Luuscher TF,Barton M. Biology of the endothlium. Clin Cardiol, 1997 ,10(suppl 1 ) : 3-10.
  • 7Dzau VJ. Tissue reninan-giohensin System: physiologic and pbsrmacologic implications. Circulation. 1998.77(Suppl I ) : 1-13
  • 8Johnston C1. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy,repair.and remodeling, Hypertension.1994,23:258-268.
  • 9Griendling KK,Alexander RW. Oxidative stress and cardiovascular disease. Circulation, 1997.96 : 3216-3265.
  • 10Luscher TF,Tanner FC, Tschudi MR. Endothelial dysfuction in coronary artery disease. Ann Rev Med.1993,44:395-418.

共引文献267

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部